sylentis.es
SYLENTIS S.A. - RNAi biopharmaceuticalsSYLENTIS, biotechnoloy company focused on the development of new therapies based on RNAi technology.
http://www.sylentis.es/
SYLENTIS, biotechnoloy company focused on the development of new therapies based on RNAi technology.
http://www.sylentis.es/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
1.8 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
20
SITE IP
83.175.205.46
LOAD TIME
1.766 sec
SCORE
6.2
SYLENTIS S.A. - RNAi biopharmaceuticals | sylentis.es Reviews
https://sylentis.es
SYLENTIS, biotechnoloy company focused on the development of new therapies based on RNAi technology.
sylentis.es
Cookies Policy
http://www.sylentis.es/index.php/en/cookies-policy
What do we search? What do we offer? DIFFERENT TYPES OF COOKIES. In accordance with Spanish Data Protection Agency guidelines, listed below are the cookies used on this website:. They are sent to the user's device from a computer or domain managed by the publisher, which provides the service requested by the user. They are sent to the user’s device from a computer or domain which is managed not by GENOMICA but, rather, by another entity which processes the data obtained from the cookies. CMS creates a co...
SYL1001
http://www.sylentis.es/index.php/en/pipeline/syl1001-en
What do we search? What do we offer? RESTRINGED HEALTH PROFESSIONAL AREA. By accessing this website you accept and agree to the following terms and conditions. In order to comply with Spanish Regulations on Advertising of Medicinal Products for Human Use, we must inform you that the information on the 'Products' area of this website is intended for qualified health care professionals with specialized training. If you are not a healthcare professional, please refrain from accessing this area.
Professional news
http://www.sylentis.es/index.php/en/news/professional-news
What do we search? What do we offer? RESTRINGED HEALTH PROFESSIONAL AREA. By accessing this website you accept and agree to the following terms and conditions. In order to comply with Spanish Regulations on Advertising of Medicinal Products for Human Use, we must inform you that the information on the 'Products' area of this website is intended for qualified health care professionals with specialized training. If you are not a healthcare professional, please refrain from accessing this area.
News
http://www.sylentis.es/index.php/en/news
What do we search? What do we offer? In accordance with Spanish law, the news section is structured into two categories: General News and professional news. Access to professional categories requires the acceptance of legal terms and conditions and the confirmation of your capacity as a health professional. Within each category syndication to RSS sources is available. You can also follow us on LinkedIn by clicking the button below. Last Modified: Wednesday 01 March 2017.
People & careers
http://www.sylentis.es/index.php/en/people-at-sylentis
What do we search? What do we offer? What do we search? What do we offer? What are we looking for? Sylentis is a dynamic company. We offer a team-oriented, highly participative work environment. Employees benefit from a creative exchange of information with peers and management, which promotes independent thinking and provides unique opportunities for motivated individuals. One of our key corporate values is inclusiveness, and we believe in ensuring equality and diversity in the workplace and through our...
TOTAL PAGES IN THIS WEBSITE
20
Pharma Jonpi .: Una prueba de orina podría ayudar a detectar el cáncer de páncreas en sus etapas iniciales, según un nuevo trabajo liderado por científicos británicos y que cuenta con la participación de varios investigadores españoles.
http://pharma-jonpi.blogspot.com/2015/08/una-prueba-de-orina-podria-ayudar.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Una prueba de orina podría ayudar a detectar el cáncer de páncreas en sus etapas iniciales, según un nuevo trabajo liderado por científicos británicos y que cuenta con la participación de varios investigadores españoles. Además, usaron muestras de 117 pacientes con otras enfermedades del hígado y de la vesícula biliar, be...
Pharma Jonpi .: Champán ayuda a prevenir el Alzheimer y otras enfermedades .
http://pharma-jonpi.blogspot.com/2015/08/champan-ayuda-prevenir-el-alzheimer-y.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Champán ayuda a prevenir el Alzheimer y otras enfermedades . Viernes 07 de Agosto de 2015. Una de las bebidas más glamourosas y que siempre se reserva para las celebraciones es, por su naturaleza, una de las grandes desconocidas más allá de por su frescura y sabor por sus beneficios para la salud. Translate / Traductor .
Pharma Jonpi .: Sanidad Pública Británica empleará Perros para la detección del Cáncer de Próstata . Reino Unido tiene una de las peores tasas de detección temprana de cáncer en Europa .
http://pharma-jonpi.blogspot.com/2015/08/sanidad-publica-britanica-empleara.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Sanidad Pública Británica empleará Perros para la detección del Cáncer de Próstata . Reino Unido tiene una de las peores tasas de detección temprana de cáncer en Europa . Según el urólogo Iqbal Anjum, las "moléculas volátiles" asociadas a los tumores se expulsan después a través de la orina del enfermo. El proyecto será d...
Pharma Jonpi .: Cáncer Bucal, una enfermedad mortal casi desconocida .
http://pharma-jonpi.blogspot.com/2015/08/cancer-bucal-una-enfermedad-mortal-casi.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Cáncer Bucal, una enfermedad mortal casi desconocida . Por Tomás Marcó del Pont Para LA NACION. El Blog Dispone de un Buscador Interno . Con el podremos Buscar , Rebuscar y Encontrar cualquier Noticia , Avance , Logro . de cualquier fecha que se haya Publicado en el Blog . Translate / Traductor . PharmaMar y Chugai Pharma...
Pharma Jonpi .: Farmacéutica Shire quiere comprar Baxalta por 30.000 Millones de Dólares ( Representa una Prima del 36 % del precio actual ) , en un intento por crear un líder mundial en tratamiento de enfermedades poco comunes.
http://pharma-jonpi.blogspot.com/2015/08/farmaceutica-shire-quiere-comprar.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Farmacéutica Shire quiere comprar Baxalta por 30.000 Millones de Dólares ( Representa una Prima del 36 % del precio actual ) , en un intento por crear un líder mundial en tratamiento de enfermedades poco comunes. La oferta en acciones de Shire, que representa una prima del 36 por ciento sobre el precio de los papeles de B...
Pharma Jonpi .: PM01183 . Tras Presentar los Resultados de la Fase Ib para el Tratamiento en Pacientes con Cáncer Microcítico de Pulmón ( SMC ) en ASCO ... Iniciara Fase III Pivotal Directamente en H215 .
http://pharma-jonpi.blogspot.com/2015/08/pm01183-tras-presentar-los-resultados.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. PM01183 . Tras Presentar los Resultados de la Fase Ib para el Tratamiento en Pacientes con Cáncer Microcítico de Pulmón ( SMC ) en ASCO . Iniciara Fase III Pivotal Directamente en H215 . Edison Healthcare Insight , May 2015 ;. El Blog Dispone de un Buscador Interno . Translate / Traductor . PharmaMar y Chugai Pharma Marke...
Pharma Jonpi .: Bamosiran ( SYL040012 ) . Sylentis ( Grupo Zeltia ) Encara la Recta Final del Ensayo de Fase IIb en el Tratamiento ARN de la HiperTensión Ocular y del Glaucoma que se lleva a cabo en EEUU , Alemania , España y Estonia .
http://pharma-jonpi.blogspot.com/2015/08/bamosiran-syl040012-sylentis-grupo.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Bamosiran ( SYL040012 ) . Sylentis ( Grupo Zeltia ) Encara la Recta Final del Ensayo de Fase IIb en el Tratamiento ARN de la HiperTensión Ocular y del Glaucoma que se lleva a cabo en EEUU , Alemania , España y Estonia . Last follow-up date : 2015-09 (Anticipated) . Primary completion date : 2015-08 (Anticipated) . Health ...
Pharma Jonpi .: Nuevo biomarcador ayuda a pronosticar riesgo de cáncer de mama .
http://pharma-jonpi.blogspot.com/2015/08/nuevo-biomarcador-ayuda-pronosticar.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Nuevo biomarcador ayuda a pronosticar riesgo de cáncer de mama . Investigadores del Imperial College de Londres y de la Fundación de Genética Humana de Torino, Italia, encontraron que los niveles de metilación en las células sanguíneas están asociados al riesgo de padecer cáncer de mama. Translate / Traductor . PharmaMar ...
Pharma Jonpi .: Yondelis Sarcoma . Elevaciones de ALT y AST son Generalmente Transitorias, Ocurren Durante los Dos Primeros Ciclos de Tratamiento y No Parecen Afectar la Supervivencia ( PFS // OS ) .
http://pharma-jonpi.blogspot.com/2015/08/yondelis-sarcoma-elevaciones-de-alt-y.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Yondelis Sarcoma . Elevaciones de ALT y AST son Generalmente Transitorias, Ocurren Durante los Dos Primeros Ciclos de Tratamiento y No Parecen Afectar la Supervivencia ( PFS / OS ) . Lack of Correlation Between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: a Retrospective Study.
Pharma Jonpi .: Supertramp cancela su gira europea tras serle diagnosticado un cáncer a Rick Davies .
http://pharma-jonpi.blogspot.com/2015/08/supertramp-cancela-su-gira-europea-tras.html
PM01183 Highest Development Phases: Phase III : Ovarian cancer; Small cell lung cancer. / / Phase II : Breast cancer; Pancreatic cancer; Sarcoma; Solid tumours. / / Phase I : Leukaemia. Supertramp cancela su gira europea tras serle diagnosticado un cáncer a Rick Davies . EFE 04.08.2015 -. Supertramp ha agradecido a sus fans el apoyo y ha pedido privacidad sobre todo este asunto, de modo que no realizará más declaraciones al respecto. El tour debía comenzar el 3 de noviembre en Oporto (Portugal) y con...
TOTAL LINKS TO THIS WEBSITE
20
Sylenth - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) " class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 4 Years. This deviant's full pageview. Last Visit: 55 weeks ago. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. Why," you ask? English is not...
sylent heart
sylenthermit09 (Wei Chong En) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 7 Years. This deviant's full pageview. Last Visit: 379 weeks ago. This is the place where you can personalize your profile! Fantasy...
sylentia22 (Mika Angelia) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Traditional Art / Hobbyist. Deviant for 3 Years. This deviant's full pageview. Last Visit: 58 weeks ago. You can drag and drop to rearrange.
.: SYLENTIS :. RNA Interference Company
Sylentis was founded in 2006 as a spin-off within the Zeltia Group, with the mission of building a solid and sustainable business and becoming a therapeutic platform based on RNA interference. Sylentis’ pipeline is directed towards indications with an elevated market potential, including ocular pathologies, inflammatory diseases and central nervous system diseases. 08/05/13 El alcalde de Tres Cantos y el concejal de Economía, Empleo y Comercio visitan las instalaciones de Sylentis. Follow us in LINKEDIN.
SYLENTIS S.A. - RNAi biopharmaceuticals
What do we search? What do we offer? Is the Best Strategy. Follow us on LINKEDIN. ARVO 2016 - SYLENTIS'S POSTERS. Sylentis Sponsors the awareness campaign "Detener el Glaucoma". A "Madrid Excelente" Company. Last Modified: Wednesday 21 December 2016.
Sylent Kulars | Photography
Fotos de selina18 lesbian. Attempts to inspire you to view the world without sounds and instead, to allow the silence of colors to invoke emotions and speak to you as you sample the images captured of a moment in time. Colors gravitate from black and white through neutrals and can finally explode with bright, vivid strokes splashed across your line of vision. Lori Siebrasse, Photographer. It's not what you look at that matters, it's what you see.
nabila izzaty
Tuesday, April 13, 2010. Subjects, Subjects, and More Subjects! We meet again. Now I’m gonna tell you again about my subjects. As you already know, they are BEL 311, BMD 101, QMT 216, CTU 241, ECO 211, FIN 262, and HKR 113. Even though this is my second time talking about the same thing, my opinion about them will remain the same forever. The first subject goes to FIN 262. The second subject is BEL 311. The third subject is BMD 101. The fourth subject is QMT 216. The fifth subject is ECO 211. Which stand...
Sylentmite
Foundation breaking – without the hassle. SYLENTMITE – Official UK Distributor. An environmentally friendly, mortar product for breaking ANY type of rock, marble, flagstone, limestone, granite and reinforced concrete in about 90 minutes depending on ambient temperature. Safe and environmentally friendly. No noise or vibrations. No flying rocks or toxic vapors. No heavy equipment or licenses. Clean, efficient, and cost effective. Demolition and concrete breaking. Partial demolition of concrete structures.
WELCOME TO SYLENTMITE & POUR 'N CRACK
Sylent Music- NJ's Premier Sounds
